1056 studies found for:    Open Studies | "Colorectal Neoplasms"
Show Display Options
Rank Status Study
21 Unknown  Cetuximab in Combination With Chemotherapy for the Treatment of Metastatic Colorectal Cancer
Conditions: Colorectal Neoplasms;   Neoplasm Metastasis;   Liver Neoplasms
Interventions: Drug: Cetuximab;   Drug: chemotherapy of mFOLFOX6 or FOLFIRI
22 Recruiting Regorafenib in Subjects With Antiangiogenic-naive and Chemotherapy-refractory Advanced Colorectal Cancer
Condition: Colorectal Neoplasms
Intervention: Drug: Regorafenib (Stivarga, BAY73-4506)
23 Unknown  Recombinant Human Endostatin in Combination With mFOLFOX6 in Patients With Metastatic Colorectal Cancer
Condition: Colorectal Neoplasm
Intervention: Drug: recombinant human endostatin (Endostat)
24 Recruiting Survivorship Care Plan in Promoting Physical Activity in Breast or Colorectal Cancer Survivors in Wisconsin
Conditions: Cancer Survivor;   Healthy Subject;   Stage I Colorectal Cancer;   Stage IA Breast Cancer;   Stage IB Breast Cancer;   Stage IIA Breast Cancer;   Stage IIA Colorectal Cancer;   Stage IIB Breast Cancer;   Stage IIB Colorectal Cancer;   Stage IIC Colorectal Cancer;   Stage IIIA Breast Cancer;   Stage IIIA Colorectal Cancer;   Stage IIIB Breast Cancer;   Stage IIIB Colorectal Cancer;   Stage IIIC Breast Cancer;   Stage IIIC Colorectal Cancer
Interventions: Other: Educational Intervention;   Other: Internet-Based Intervention;   Device: Monitoring Device;   Other: Quality-of-Life Assessment;   Other: Questionnaire Administration
25 Recruiting Anti-OX40 Antibody (MEDI6469) in Patients With Metastatic Colorectal Cancer
Condition: Colorectal Neoplasms
Intervention: Drug: MEDI6469
26 Recruiting Safety Study of Regorafenib and SIR-Spheres® Microspheres Radioembolization in Patients With Refractory Metastatic Colorectal Cancer With Liver Metastases
Condition: Colorectal Neoplasms
Interventions: Device: SIR-Spheres;   Drug: Regorafenib
27 Recruiting Regorafenib as Single Agent in Patients With Metastatic Colorectal Cancer (mCRC) With Any RAS or BRAF Mutation Previously Treated With FOLFOXIRI Plus Bevacizumab
Conditions: Colorectal Neoplasms;   Metastatic Disease
Intervention: Drug: Regorafenib
28 Recruiting A Single Arm, Open-label Clinical Trial to Evaluate the Efficacy and Safety of Maintenance Treatment With Capecitabine Plus Cetuximab in Metastatic Colorectal Cancer
Condition: Colorectal Neoplasms
Intervention: Other: maintenance treatment with capecitabine plus cetuximab
29 Recruiting Selumetinib and Cyclosporine in Treating Patients With Advanced Solid Tumors or Advanced or Metastatic Colorectal Cancer
Conditions: Recurrent Colorectal Carcinoma;   Solid Neoplasm;   Stage IIIA Colorectal Cancer;   Stage IIIB Colorectal Cancer;   Stage IIIC Colorectal Cancer;   Stage IVA Colorectal Cancer;   Stage IVB Colorectal Cancer
Interventions: Drug: Cyclosporine;   Other: Laboratory Biomarker Analysis;   Other: Pharmacological Study;   Drug: Selumetinib
30 Unknown  Collecting Information From Patients and Family Members With Hereditary Colorectal Cancer Syndromes or Who Are at High Risk of Developing Colorectal Cancer
Conditions: Colorectal Cancer;   Hereditary Nonpolyposis Colorectal Cancer;   Precancerous Condition
Interventions: Other: study of socioeconomic and demographic variables;   Procedure: evaluation of cancer risk factors;   Procedure: study of high risk factors
31 Recruiting Efficacy of Cap-assisted Chromoendoscopy as a Screening Test for Colorectal Neoplasm Using Web-based Research Network
Condition: Colorectal Neoplasm
Intervention: Device: cap-assisted chromoendoscopy
32 Recruiting Ohio Colorectal Cancer Prevention Initiative
Conditions: Lynch Syndrome;   Colorectal Cancer
Interventions: Genetic: LS tumor screening;   Genetic: Genetic testing;   Behavioral: Genetic Counseling;   Other: Biorepository;   Behavioral: Questionnaire
33 Not yet recruiting Addition of Systemic Therapy to Surgery and HIPEC for Colon Cancer With Peritoneal Metastases: the CAIRO6 Trial
Conditions: Colorectal Neoplasms;   Colorectal Cancer;   Colorectal Carcinoma;   Colorectal Tumors;   Peritoneal Neoplasms;   Peritoneal Diseases
Interventions: Drug: FOLFOX + bevacizumab;   Drug: CAPOX + bevacizumab;   Drug: FOLFOX;   Drug: CAPOX
34 Unknown  Endolaparoscopic Versus Immediate Surgery for Obstructing Colorectal Cancers
Conditions: Colorectal Cancer;   Bowel Obstruction
Intervention: Procedure: Endoscopic stenting followed by elective laparoscopic resection
35 Recruiting Colorectal Cancer With Liver-limited Synchronous Metastases: an Inception Cohort Study of Standardised Care Pathways
Conditions: Colorectal Neoplasms;   Liver Neoplasms;   Neoplasm Metastasis
Interventions: Procedure: Primary/Bowel-first Surgery;   Procedure: Liver-first surgery;   Procedure: Synchronous resection surgery;   Procedure: No surgery
36 Recruiting Familial Colorectal Cancer Registry in Hispanics
Condition: Colorectal Cancer
Intervention:
37 Recruiting Effects of Yoga on Cognitive and Immune Function in Colorectal Cancer
Condition: Colorectal Neoplasms
Interventions: Other: Yoga;   Other: Physical Activity
38 Recruiting Colorectal Cancer Registry
Condition: Colorectal Cancer
Intervention: Other: non-interventional
39 Recruiting Neurotoxic Symptoms in Adjuvant Chemotherapy in Patients With Colorectal Cancer
Condition: Colorectal Neoplasms
Intervention: Other: oxaliplatin
40 Recruiting Assessment of Physical Activity During Therapy With Regorafenib for Metastatic Colorectal Cancer
Condition: Colorectal Neoplasms
Intervention: Drug: Regorafenib (Stivarga, BAY73-4506)

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years